PegBio (HKG:2565) applied to the China Securities Regulatory Commission to convert over 101.7 million unlisted shares held by 20 shareholders into Hong Kong-listed shares, a Friday filing with the Hong Kong bourse said.
The shares represent roughly 26.35% of the biopharmaceutical company's issued share capital.
The firm will make announcements regarding the Hong Kong-listed share full circulation as and when needed.